Beroni Group Limited
Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics, and viral diagnostic kits in China. It operates through four segments: Cell Therapies; Developing New Anti-Cancer Drugs; E-commerce Platform for Pharmaceutical and Healthcare Products; and Det… Read more
Beroni Group Limited (BNIGF) - Net Assets
Latest net assets as of June 2024: $5.56 Million USD
Based on the latest financial reports, Beroni Group Limited (BNIGF) has net assets worth $5.56 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.44 Million) and total liabilities ($2.88 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.56 Million |
| % of Total Assets | 65.87% |
| Annual Growth Rate | N/A |
| 5-Year Change | -100.0% |
| 10-Year Change | N/A |
| Growth Volatility | 144.01 |
Beroni Group Limited - Net Assets Trend (2015–2023)
This chart illustrates how Beroni Group Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Beroni Group Limited (2015–2023)
The table below shows the annual net assets of Beroni Group Limited from 2015 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-214.00 | -100.00% |
| 2022-12-31 | $7.58 Million | -8.72% |
| 2021-12-31 | $8.31 Million | -17.42% |
| 2020-12-31 | $10.06 Million | -23.36% |
| 2019-12-31 | $13.13 Million | -28.05% |
| 2018-12-31 | $18.24 Million | +68.69% |
| 2017-12-31 | $10.82 Million | +401.97% |
| 2016-12-31 | $2.15 Million | +28.10% |
| 2015-12-31 | $1.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Beroni Group Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4196511900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $42.10 Million | % |
| Total Equity | $-161.20K | 100.00% |
Beroni Group Limited Competitors by Market Cap
The table below lists competitors of Beroni Group Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tae Kyung Chemical Co. Ltd.
KQ:006890
|
$59.06K |
|
GOODYEAR T & RUBBER
DU:GTR
|
$59.11K |
|
HBTS5F
SA:HBTS5F
|
$59.12K |
|
CURY3F
SA:CURY3F
|
$59.16K |
|
Turn Cloud Technology Service Inc.
TWO:6870
|
$59.04K |
|
THG Holdings PLC
LSE:THG
|
$58.98K |
|
QINETIQ GROUP - Dusseldorf Stock Exchang
DU:QY6
|
$58.97K |
|
RYOTF
PINK:RYOTF
|
$58.95K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beroni Group Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 7,261,042 to -161,197, a change of -7,422,239 (-102.2%).
- Net loss of 9,227,128 reduced equity.
- Other factors increased equity by 1,804,889.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-9.23 Million | -5724.13% |
| Other Changes | $1.80 Million | +1119.68% |
| Total Change | $- | -102.22% |
Book Value vs Market Value Analysis
This analysis compares Beroni Group Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.01 | x |
| 2016-12-31 | $0.00 | $0.01 | x |
| 2017-12-31 | $0.15 | $0.01 | x |
| 2018-12-31 | $0.25 | $0.01 | x |
| 2019-12-31 | $0.18 | $0.01 | x |
| 2020-12-31 | $0.12 | $0.01 | x |
| 2021-12-31 | $0.10 | $0.01 | x |
| 2022-12-31 | $0.09 | $0.01 | x |
| 2023-12-31 | $-0.01 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beroni Group Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1968.54%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-35.26%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -9.46% | -14.41% | 0.45x | 1.45x | $-327.35K |
| 2016 | 22.09% | 10.91% | 0.96x | 2.11x | $260.42K |
| 2017 | -6.70% | -31.65% | 0.20x | 1.04x | $-1.81 Million |
| 2018 | -13.28% | -112.21% | 0.12x | 1.02x | $-4.26 Million |
| 2019 | -58.31% | -457.58% | 0.11x | 1.11x | $-9.10 Million |
| 2020 | -106.51% | -556.44% | 0.15x | 1.24x | $-10.92 Million |
| 2021 | -33.99% | -121.24% | 0.18x | 1.52x | $-3.45 Million |
| 2022 | -111.14% | -1263.03% | 0.06x | 1.43x | $-8.80 Million |
| 2023 | 0.00% | -1968.54% | 0.05x | 0.00x | $-9.21 Million |
Industry Comparison
This section compares Beroni Group Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beroni Group Limited (BNIGF) | $5.56 Million | -9.46% | 0.52x | $59.06K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |